To Evaluate the Effect of Reveratrol,Folic Acid, Vitamin D, Vitamin B12 and B6 in Male Infertility

NCT03864198 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-03-06

No results posted yet for this study

Summary

The objective of this study is to evaluate the impact of the Genante(TM) on the spermiogram parameters in infertile male patients

Conditions

  • Male Infertility

Interventions

DIETARY_SUPPLEMENT

Genante

A dietary supplement for male infertility

Sponsors & Collaborators

  • Ester Illiano, MD

    collaborator UNKNOWN
  • University Of Perugia

    lead OTHER

Principal Investigators

  • Ester Illiano, MD · University Of Perugia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-20
Primary Completion
2019-03-20
Completion
2019-04-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03864198 on ClinicalTrials.gov